What question did this study set out to answer?

To characterize the remodeling of the bone marrow immune and stromal niche in myelodysplastic neoplasm patients under therapy.

December 8, 2025Blood

Bone marrow immune and stromal niche remodeling in myelodysplastic neoplasm patients under erythropoietic therapies by 29-color full-spectrum flow cytometry

View Full Paper

Ask AI

Bookmark

Authors

CJClàudia Pellín JouHebron University PAPamela AchaHebron University AGAna Pérez GonzálezHebron University

Discussion

Member takes

Implication

Observations reveal immune niche remodeling in myelodysplastic neoplasms patients under erythropoiesis-stimulating agents, suggesting implications for therapy effectiveness.

Key Points

To characterize the remodeling of the bone marrow immune and stromal niche in myelodysplastic neoplasm patients under therapy.
Analyzed cryopreserved bone marrow mononuclear cells from three LR-MDS patients undergoing different treatments.
Used 29-color full-spectrum flow cytometry to profile hematopoietic and non-hematopoietic populations.
Compared findings to an age-matched control from a lymphoma patient.
Immune profiling showed a 65% increase in endothelial progenitor cells and a 52% decrease in primitive mesenchymal stromal cells.
Myeloid-derived suppressor cells decreased by 93%, while plasmacytoid dendritic cells increased by 810% after treatment.
Treatment with TGF-β ligand traps resulted in greater modulation of the bone marrow microenvironment compared to erythropoiesis-stimulating agent.

Cite This Study

Jou et al. (2025) studied this question.

synapsesocial.com/papers/69362f4b4fa91c937236d821 https://doi.org/10.1182/blood-2025-3183

View Full Paper

Ask AI

Bookmark

Implication

Observations reveal immune niche remodeling in myelodysplastic neoplasms patients under erythropoiesis-stimulating agents, suggesting implications for therapy effectiveness.

Bone marrow immune and stromal niche remodeling in myelodysplastic neoplasm patients under erythropoietic therapies by 29-color full-spectrum flow cytometry

Discussion

Member takes

Implication

Key Points

Cite This Study

Bone marrow immune and stromal niche remodeling in myelodysplastic neoplasm patients under erythropoietic therapies by 29-color full-spectrum flow cytometry

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider